Affecting 1% of the population, celiac disease is one of the world’s most prevalent genetic autoimmune conditions. In the United States, celiac disease is also one of the least diagnosed, with an estimated 2.5 million children and adults continuing to suffer needlessly. Long-term health complications of undiagnosed celiac disease include cancers, coronary heart disease, osteoporosis, […]
The U.S Preventative Services Task Force (USPSTF) will be researching and posting a final recommendation statement regarding screening for celiac disease. This screening recommendation will provide information that is “valid, reliable, and useful to health professionals, patients and family members.” Prior to beginning the comprehensive research process, the USPSTF will be posting their draft research […]
While the prevalence of celiac disease is estimated to be about 1% in the United States, the number of people who have adopted a gluten-free diet is far greater, as shown by the rapidly expanding gluten-free market. For those people who feel better on a gluten-free diet but have tested negative for celiac disease and […]
Celiac disease, typically thought of as a gastrointestinal disease, has a wide variety of symptoms that can affect other parts of the body including the mind. Many people with celiac disease report having “brain fog”, a form of cognitive impairment can encompass disorientation, problems with staying focused and paying attention, and lapses in short-term memory. […]
The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one that found a link between celiac disease and an absence of H. pylori in the stomach. Another paper, involving three of the same doctors, including Celiac Disease Foundation’s own Medical Advisory Board Member Dr. Peter Green, found another possible explanation.
In honor of May Celiac Disease Awareness Month, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) is proud to team with Celiac Disease Foundation. LabCorp is dedicated to raising awareness of celiac disease and to helping more people reach a diagnosis. LabCorp’s comprehensive celiac services program includes cost effective antibody testing profiles and HLA DQA/DQB […]
Alex Morris may only be 12, but the seventh grader is going well beyond her years in organizing a 5K race to benefit a celiac disease charity.
Alex, a student at Naperville’s Washington Junior High, like many Americans, suffers from the incurable autoimmune disorder gluten-sensitive enteropathy that commonly is treated by abstaining from foods containing wheat products.
Eating nothing but gluten-free foods requires self-discipline. But people who have celiac disease must follow the strict diet or face the consequences, says Danielle Nebel, a junior at Calabasas High School who was diagnosed with the autoimmune disorder when she was 2½ years old.
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.
A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first posted online on April 21, 2014, titled “Increased Prevalence of Celiac Disease Among Pediatric Patients With Irritable Bowel Syndrome” examined nearly a thousand Italian children […]